TY  - JOUR
AU  - Castillo Romero, Rafael
AU  - Colilla Nieto, Montserrat
AU  - Vallet Regí, María Dulce Nombre
PY  - 2016
DO  - 10.1080/17425247.2016.1211637
SN  - 1742-5247
UR  - https://hdl.handle.net/20.500.14352/17581
T2  - Expert Opinion on Drug Delivery
AB  - Introduction: Nanocarriers have emerged as a powerful alternative for cancer therapy.Indeed, they are promising candidates to tackle the acquired resistance of surviving cells against antiproliferative drugs – the so-called multidrug resistance (MDR)...
LA  - spa
M2  - 229
PB  - Taylor & Francis
KW  - Cancer treatment
KW  - multidrug resistance
KW  - co-delivery
KW  - combination therapy
KW  - dual targeting
KW  - mesoporous silicananoparticles
TI  - Advances in mesoporous silica-based nanocarriers for co-delivery and combination therapy against cancer
TY  - journal article
VL  - 14
ER  -